摘要
目的探讨重组白细胞介素-2治疗带状疱疹的疗效和安全性。方法患者随机分为两组,治疗组皮下注射重组白细胞介素-2 10万U/d,对照组口服阿昔洛韦缓释片1600mg,3次/d。两组疗程均为10d。结果重组白细胞介素-2在止疱、止痛、结痂时间上均明显低于对照组,P<0.05。结论重组白细胞介素-2治疗带状疱疹不良反应小,起效较快,能有效缩短病程,降低后遗神经痛的发生率。
Objective Explore the efficacy and safety of recombinant interleukin 2 treatment of herpes zoster. Methods Patients were randomly divided into two groups, Subcutaneous injection of recombinant interleukin-2 treatment groups 100,000 U/ d, Control group oral acyclovir 1600rag sustained-release tablets, 3 times daily. Two sets of courses of up to 10 days. Results Recombinant interleukin-2 in only blisters, pain, the scab time were significantly lower than the control group （ P 〈 0. 05 ）. Conclusion Herpes zoster treated with recombinant interleuldn-2 has small side-effects, work faster, can effectively shorten the course, reduce the incidence of PHN.
出处
《四川医学》
CAS
2012年第5期858-859,共2页
Sichuan Medical Journal
